Allied Market Research
image  Direct : +1 (617) 674-4143 | Toll Free : +1 (855) 711-1555

Report Image
Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 - 2020
Published: Dec-2013    |    Formats: PDF & Excel   |   Author(s):Debbie Shields   |   Code: ME 1388
  • Report
    Overview
  • Table of
    Contents
  • Research
    Methodology
  • Analyst's
    Review

Pages
92

Rise in incidence of diabetes across the globe has elevated the need of innovative diabetic management devices that has increased adoption of continuous glucose monitoring (CGM) devices. The existing glucose monitoring devices have few gaps which are bridged by the innovative CGM. With continuous glucose monitoring, significant improvement has been observed in stabilizing elevated A1C levels which in turn reduces risk of developing long term diabetic complications. Other driving factors for CGM market are technological innovation in the form of artificial pancreas, increasing awareness among developed, developing and under developed economies, and rise in incidences of diabetic cases. However, factors such as strict regulatory impositions, inadequate reimbursement options for CGM, lack of accurate results and cost of the CGMs are restraining the market growth.The global continuous glucose monitors market generated revenue of $194.8 million in 2012 and is expected to reach market size of value $568.5 million by 2020, growing at a CAGR of 14.8% during 2013-2020. This growth is attributed to increase in technological innovations, namely launch of artificial pancreas, convenience offered by CGM over self monitoring glucose devices, and earlier detection of the hypo & hyperglycemic events by CGM.

Global CGM market is segmented based on application as home settings, diagnostics and hospitals. Among all the application segments home settings is expected to generate maximum revenue by 2020.

North America is the maximum revenue-generating segment across the globe, mainly due to rapid acceptance of innovative technology, well-penetrated reimbursement system when compared with other geographies and rise in patient pool. Asia Pacific is expected to grow at a faster rate due to large patient pool, geographical expansion of market players, increase in income levels and improved living standards of the people.

Key market players in this market includes, Medtronics, Dexcom, Animas Corporation, Ypsomed AG, Omnipod and Miraculins, Inc inlcuding others. The major strategies adopted by the market players across geographies are Collaborations, Product launches and approvals. Collaborations in the regions focus on distribution and commercialization of the devices.

Continuous Glucose Monitoring Market brings good news for medical device manufacturers.

KEY BENEFITS

  • The report ranks the factors that are responsible to accelerate the market growth driven by upper hand of CGM over Self monitoring glucose devices, approval for artificial pancreas and many more
  • Market is forecast for the period 2013 - 2020 with market revenues for 2 historic years of 2010 and 2012
  • Identification and analysis of key pockets of investment for CGM manufacturers
  • Identification of challenges that must be addressed and overcome in the CGM market to achieve fiscal success throughout the market
  • Analysis of regulatory framework that regulates introduction of new CGM and puts light on reimbursement scenario
  • The report identifies and profiles key market participants that would drive innovation in the CGM market

KEY MARKET SEGMENTS

GLOBAL MARKET, BY DEVICES

  • Transmitter and Receivers
  • Sensors
  • Insulin Pump

GLOBAL MARKET, BY APPLICATION

  • Diagnostics/Clinics
  • Hospitals
  • Home Settings

GLOBAL MARKET, BY AGE

  • Children and Teens
  • Youth
  • Middle, Elderly and Aged

GLOBAL MARKET, BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific
  • Row

KEY AUDIENCES

  • Medical Devices Manufacturers
  • Research Institutions
  • Healthcare Institutions

Tables
26

CHAPTER 1 INTRODUCTION

1.1 Objectives and Scope
1.2 Report Description
1.3 Key Benefits of the Report
1.4 Research Methodology

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 GLOBAL CONTINUOUS GLUCOSE MONITORS MARKET OVERVIEW

3.1 Healthcare Expenditure on Diabetes Worldwide
3.2 Type-1 Diabetics to Remain Key Target for CGM Market

3.2.1 Type-1 Diabetes

3.2.1.1 Type-1 Diabetes in Young People

3.2.2 Type-2 Diabetes

3.2.2.1 Type-2 Diabetes in Young People

3.2.3 Gestational Diabetes
3.2.4 Other Types of Diabetes

3.3 Market Intelligence

3.3.1 Top Factors Impacting Continuous Glucose Monitors Market, 2013-2020

3.3.1.1 Fda Approval of Artificial Pancreas
3.3.1.2 Convenience Offered by CGM Over Self Monitoring Glucose Devices
3.3.1.3 Rise in Incidences of Diabetes Cases Globally
3.3.1.4 Earlier Detection of the Hypo and Hyperglycemic Events by CGM
3.3.1.5 Inadequate Reimbursement Options for CGM Serve as Barriers for its Adoption
3.3.1.6 Accuracy and Cost Acts as a Hindrance in Continuing Use of CGM
3.3.1.7 Strict Regulatory Impositions
3.3.1.8 Increase in Awareness Among Developing and Underdeveloped Economies

3.3.2 Top Three Winning Strategies in the Continuous Glucose Monitors Market
3.3.2.1 Global Market Players Positioning
3.3.3 Top Investment Pockets in Continuous Glucose Monitors Market

3.3.3.1 Continuous Glucose Monitors Market – by Device
3.3.3.2 Continuous Glucose Monitors Market – by Applications
3.3.3.3 Continuous Glucose Monitors Market – by Geography

3.4 Regulations
3.5 Reimbursement Scenario
3.6 Market Dynamics

3.6.1 Drivers

3.6.1.1 Convenience Offered by CGM Over Self Monitoring Glucose Devices
3.6.1.2 FDA Approval of Artificial Pancreas Enables Closing the Loop and Overcomes the Limitation of Current Diabetes Care Management System
3.6.1.3 Earlier Detection of the Hypo and Hyperglycemic Events by CGM
3.6.1.4 Rise in Incidences of Diabetes Cases Globally
3.6.1.5 Increase in Awareness Among the Population in Developing and Underdeveloped Economies

3.6.2 Restraints

3.6.2.1 Strict Regulatory Impositions
3.6.2.2 Inadequate Reimbursement Options for CGM Serve as Barriers for its Adoption
3.6.2.3 Accuracy and Cost Acts as a Hindrance in Continuing Use of CGM

3.6.3 Market Opportunity

3.6.3.1 Growth in Emerging Market

3.6.4 Winning Strategies for Mncs in Emerging Markets

3.6.4.1 Tailoring the Existing Products to the Local Market Needs
3.6.4.2 Adoption of a Proactive Hybrid Model Rather Than Distributor Management
3.6.4.3 Service Rendered Makes a Difference
3.6.4.4 Partnership and Acquisition Key to Enhance Reach and Market Position
3.6.4.5  Adopting An Emerging-Market Attitude

CHAPTER 4 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY DEVICES

4.1 Transmitter and Receivers
4.2 Sensors

4.2.1 Market Trend

4.2.1.1 Non-Invasive Glucose Sensors
4.2.1.2 Subcutaneous Sensors (Minimally Invasive Sensors)
4.2.1.3 Conventional Technology – Holter-Type Retrospective Sensors
4.2.1.4 Advanced Technology – Real-Time Sensors

4.3 Insulin Pump

4.3.1 Advantages of Insulin Pump
4.3.2 Disadvantages of Insulin Pump
4.3.3 Market Trend

CHAPTER 5 CONTINUOUS GLUCOSE MONITORING SYSTEM MARKET - BY APPLICATION

5.1 Diagnostics/Clinics
5.2 Hospitals
5.3 Home Settings
5.4 Role of CGM in Private Practice

5.4.1 Team Members
5.4.2 Clinical Space
5.4.3 Scheduling
5.4.4 Keeping the Patients Informed

CHAPTER 6 CONTINUOUS GLUCOSE MONITORING SYSTEM MARKET – BY AGE

6.1 Children and Teens
6.2 Youth
6.3 Middle Elderly and Aged

CHAPTER 7 CGM SYSTEMS MARKET BY GEOGRAPHY

7.1 North America
7.2 Europe
7.2.1 Financial Cost Incurred
7.3 Asia Pacific
7.4 Row

CHAPTER 8 COMPANY PROFILES

8.1 Medtronic Inc.

8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Business Performance
8.1.4 Strategic Moves and Developments

8.1.4.1 Principal Strategies: Product Launch
8.1.4.2 Secondary Strategies: Approval
8.1.4.3 Other Strategies: Collaboration

8.1.5 SWOT Analysis & Strategic Conclusions

8.2 Dexcom Inc.

8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Business Performance
8.2.4 Strategic Moves and Developments

8.2.4.1 Principal Strategies: Agreement/Partnership
8.2.4.2 Secondary Strategies: Acquisition

8.2.5 SWOT Analysis & Strategic Conclusions

8.3 Novo Nordisk

8.3.1 Company Profile
8.3.2 Company Snapshot
8.3.3 Strategic Moves and Developments
8.3.4 SWOT Analysis & Strategic Conclusions

8.4 Spring Health Solution Ltd

8.4.1 Company Profile
8.4.2 Company Snapshot
8.4.3 Strategic Moves and Developments

8.4.3.1 Principal Strategies

8.4.4 SWOT Analysis & Strategic Conclusions

8.5 Roche

8.5.1 Company Profile
8.5.2 Company Snapshot
8.5.3 Strategic Moves and Developments
8.5.4 SWOT Analysis & Strategic Conclusions

8.6 Animas Corporation

8.6.1 Company Profile
8.6.2 Company Snapshot
8.6.3 Strategic Moves and Developments

8.6.3.1 Principal Strategies

8.6.4 SWOT Analysis & Strategic Conclusions

8.7 Ypsomed AG

8.7.1 Company Profile
8.7.2 Company Snapshot
8.7.3 Strategic Moves and Developments

8.7.3.1 Principal Strategies: Product Expansion
8.7.3.2 Secondary Strategies: New Subsidiary
8.7.3.3 Other Strategies: Acquisition and Agreements

8.7.4 SWOT Analysis & Strategic Conclusions

8.8 Insulet Corporation

8.8.1 Company Profile
8.8.2 Company Snapshot
8.8.3 Strategic Moves and Developments

8.8.3.1 Principal Strategies

8.8.4 SWOT Analysis & Strategic Conclusions

 

LIST OF TABLES

TABLE 1 FEATURES OF CURRENTLY AVAILABLE STAND-ALONE CGM SYSTEMS (AS OF MARCH 2013)
TABLE 2 FEATURES OF CURRENTLY AVAILABLE INTEGRATED CGM SYSTEMS (AS OF MARCH 2013)
TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY PRODUCT CATEGORY, 2011-2020, ($MILLION)
TABLE 4 GLOBAL CGM TRANSMITTERS AND RECEIVERS MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 5 GLOBAL CGM SENSORS MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 6 GLOBAL CGM INSULIN PUMP MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 7 GLOBAL CGM MARKET BY APPLICATION SEGMENTS, 2011 - 2020, ($MILLION)
TABLE 8 GLOBAL CGM MARKET IN DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2011 - 2020, ($THOUSAND)
TABLE 9 GLOBAL CGM MARKET IN HOSPITALS, BY GEOGRAPHY, 2011 - 2020, ($THOUSAND)
TABLE 10 GLOBAL CGM MARKET IN HOME SETTINGS, BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 11 GLOBAL CGM MARKET BY AGE, 2011 - 2020, ($MILLION)
TABLE 12 TYPE-1 DIABETES (0-14 YEARS), 2013
TABLE 13 FACTORS IMPACTING GEOGRAPHICAL REGIONS IN 2013 AND 2020
TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS BY GEOGRAPHY, 2011 - 2020, ($MILLION)
TABLE 15 THE PREVALENCE OF DIABETES IN THE ADULT POPULATION ACROSS THE U.K. IN 2011
TABLE 16 PREVALENCE ESTIMATES OF DIABETES (20-79 YEARS), 2013, EUROPE
TABLE 17 PREVALENCE ESTIMATES OF DIABETES, 2013 & 2035
TABLE 18 PREVALENCE ESTIMATES OF DIABETES (20-79 YEARS), 2013, AFRICA REGION
TABLE 19 MEDTRONIC BUSINESS SNAPSHOT
TABLE 20 DEXCOM INC. BUSINESS SNAPSHOT
TABLE 21 NOVA NORDISK BUSINESS SNAPSHOT
TABLE 22 SPRING HEALTH SOLUTION LTD BUSINESS SNAPSHOT
TABLE 23 ROCHE BUSINESS SNAPSHOT
TABLE 24 ANIMAS CORPORATION BUSINESS SNAPSHOT
TABLE 25 YPSOMED AG BUSINESS SNAPSHOT
TABLE 26 INSULET CORPORATION BUSINESS SNAPSHOT


LIST OF FIGURES

FIG. 1 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES, BY GEOGRAPHY ($BILLION)
FIG. 2 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES, 20-79 YEARS ($BILLION)
FIG. 3 TREATMENT OF DIABETES, 2011
FIG. 4 SIMILARITIES IN CAUSE OF PRE-DIABETES AND TYPE-2 DIABETES
FIG. 5 CGM ADOPTION BY DIFFERENT TYPES OF DIABETES PATIENTS
FIG. 6 PREVALENCE OF TYPE-1 DIABETES, BY GEOGRAPHY, (THOUSAND)
FIG. 7 GLOBAL PREVALENCE OF TYPE-2 DIABETES IN 2000 & ESTIMATED PREVALENCE IN 2030
FIG. 8 TOP FACTORS IMPACTING CGM MARKET, 2013-2020
FIG. 9 TOP WINNING STRATEGY IN CGM MARKET, 2010 TO 2013 (SEPTEMBER)
FIG. 10 TOP WINNING STRATEGY IN CGM MARKET BY YEAR
FIG. 11 GLOBAL MARKET PLAYERS POSITIONING
FIG. 12 TOP INVESTMENT POCKETS IN CGM DEVICE MARKETS
FIG. 13 TOP INVESTMENT POCKETS IN CGM APPLICATION MARKETS
FIG. 14 TOP INVESTMENT POCKETS IN CGM GEOGRAPHY MARKETS
FIG. 15 NUMBER OF INCIDENCES OF DIABETES GLOBALLY, BY GEOGRAPHY (2000, 2011 & 2030)
FIG. 16 GDP PER CAPITA IN EMERGING ECONOMIES
FIG. 17 EMERGING MARKET CAPITALIZATION STRATEGIES
FIG. 18 GLOBAL CGM MARKET AMONG CHILDREN, 2011-2020, ($MILLION)
FIG. 19 GLOBAL CGM MARKET AMONG TEENS, 2011-2020, ($MILLION)
FIG. 20 GLOBAL CGM MARKET AMONG YOUTH, 2011-2020, ($MILLION)
FIG. 21 GLOBAL CGM MARKET AMONG MIDDLE ELDERLY, 2011-2020, ($MILLION)
FIG. 22 GLOBAL CGM MARKET AMONG AGED, 2011-2020, ($MILLION)
FIG. 23 NORTH AMERICA CGM MARKET, 2013-2020, ($MILLION)
FIG. 24 CASES OF DIABETES BY AGES IN NAC (1000S) (2013 E)
FIG. 25 EUROPE CGM MARKET, 2013-2020, ($MILLION)
FIG. 26 CASES OF DIABETES BY AGES IN EUROPE (1000S) (2013 E)
FIG. 27 ASIA PACIFIC CGM MARKET, 2013-2020, ($MILLION)
FIG. 28 TOP 10 COUNTRIES WITH DIABETES INCIDENCES 2013 AND 2035
FIG. 29 ROW CGM MARKET, 2013-2020, ($MILLION)
FIG. 30 FINANCIAL REVENUES BY BUSINESS UNITS (2013)
FIG. 31 FINANCIAL REVENUES BY GEOGRAPHY (2013)
FIG. 32 FINANCIAL REVENUES BY GEOGRAPHY (2012)

With collective industry experience of about 100 years from its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus like the view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future courses of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to take informed decisions to attain their highest growth objectives.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play a key role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advices. With AMR’s calibrated research process and 360-degree data evaluation methodology, our clients are assured of receiving:

  •  Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  •  Technologically sophisticated and reliable insights through well audited and researched methodologies
  •  Sovereign research proceeds that present a tangible depiction of the marketplace

With a strong methodology, we are, confident that our research and analysis are most reliable and guarantee sound business planning.

For this research report, we conducted about over 75 hours of interviews and discussion with wide range of stakeholders including upstream and downstream participants. Primary research typically is bulk of our research efforts; however, coherently supported by extensive secondary research. We reviewed over 5000 product literatures, industry releases, annual reports and other such documents of key industry participants for better market understanding and competitive intelligence. Additionally, authentic industry journals, trade associations’ releases and government websites have also been reviewed for generating high value industry insights..

Secondary research

We refer to a broad array of industry sources for our secondary, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
  •  Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation

Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecasts

Primary research

Our primary research efforts include reaching out for participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions.  We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions fulfilling following functions:

  •  Validates and improves the data quality and strengthens research proceeds
  •  Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation expertsKey opinion leaders (KOLs)

Analyst tools and models

AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analytical tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

The global continuous glucose monitors (CGM) market is at its emerging state. The market has witnessed launch of various continuous glucose monitoring devices in last 7 to 8 years with continuous improvement in technology. Furthermore, innovations are expected to translate the entire market scenario in the coming five to seven years. The open loop continuous glucose monitoring can now be regarded as closed with the introduction of artificial pancreas named MiniMed 530G with Enlite by Medtronic in September 2013. Launch of this product has taken diabetic care management to a next level. The market is overcoming several challenges towards the commercialization of closed loop CGMs due to significant focus on technological innovation. This is expected to take the concept of CGMs to a next level from research to large level adoption. Major factors driving the market growth are convenience offered by CGM over conventional glucose monitoring devices, earlier detection of the Hypo and Hyperglycemic events, global rise in incidences of diabetes cases, and awareness among global population. This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.
SIMILAR MARKET STUDIES

Published Reports

In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. The global IVD market is segmented based on techniques, product type, usability, application, end user and geography (North America, Europe, Asia Pacific and Rest of World). Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020. Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market.
3 Jun 2014 | Price: $4515(SU) | View Details >>

The male infertility market is expected to grow to $301.5 million by 2020 with a CAGR of 4.9% during 2013-2020. Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. 20% of the total infertility is due to male factors. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing to the rise in male infertility levels. The major limitation experienced in the male infertility market is due to repeated treatment failures leading to an emotional impact on the patient.
29 Apr 2014 | Price: $4515(SU) | View Details >>

The advancement of IVF market in Asia Pacific is characterized by major factors such as the rising standards of living and growing number of couples delaying parenthood due to professional and financial commitments. The Asia Pacific IVF market, valued at $1.3 billion in 2012, is estimated to reach $4.2 billion by 2020. As the chances of conceiving lowers with age, delayed pregnancy in women is one of the major driving factors of the IVF market. The success rate of getting pregnant with IVF technique is higher within the age group of 35-39. Other driving factors of the IVF market are rise in infertility rates due to rise in stress levels, change in life style and fertility related diseases.
18 Mar 2014 | Price: $5315(SU) | View Details >>

In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. The pregnancy success rate with IVF technique is higher in the age group of 35-39.Globally, the number of couples with infertility issues was found to be 48.5 million in 2010.
29 Jan 2014 | Price: $4515(SU) | View Details >>

Traditional wound care & closure and advanced wound care & closure products are used to treat acute and chronic wounds. Chronic wounds are hard to heal wounds, which take substantial time to heal and are expensive to treat. Advanced wound care & closure products are emerging as a standard solution for treating chronic wounds.
22 Jul 2014 | Price: $4515(SU) | View Details >>

Upcoming Reports

Intravenous Access Devices are a prominent sector of the Healthcare industry. These devices are used by physicians for treating patients as well as testing blood after withdrawing it via intravenous route. Intravenous access devices are used for administering all the classes of drugs like antibiotics, antipyretics and analgesics. Rising incidences of different diseases such as tuberculosis, cancer and others are the key drivers of this market. Moreover, urbanization and growing geriatric population all over the world boost the growth of the Intravenous (IV) Access Devices market.
Price: $4515 | Pre Book Price: $4515 | View Details >>

An Arthroscopy is a procedure for diagnosing and treating joints related problems. It is used commonly to deal with the knees, wrist, ankles, elbows and shoulders. The rising awareness of different sports, many youngsters are involved in outdoor activities, which has increased injuries related to sports. Moreover, rise in obesity, growing aging population, and also increasing prevalence of musculoskeletal disorders such as rheumatoid arthritis, bone tumor, osteoarthritis and others are the drivers for the growth of this market. The report is considering advance and conventional medical equipments. The report provides a key trend that affects market growth, technology offerings and competitive landscape.
Price: $4515 | Pre Book Price: $4515 | View Details >>

Radiofrequency ablation is medical process, in which high frequency electromagnetic waves are used to generate heat for the treatment of medical conditions. It has applications in various fields of medicine such as pain management, cosmetology, cardiac rhythm management, oncology, renal denervation for hypertension.
Price: $4515 | Pre Book Price: $4515 | View Details >>

ECG Monitoring Systems are medical devices, which identify and give information about abnormal functioning of the heart. Rest ECG recorders, ECG stress testing systems, event recorders and Holter monitors are the part of ECG Monitoring systems. Cardiovascular diseases such as coronary heart diseases and strokes are estimated to be the leading cause of deaths worldwide. In order to prevent cardiovascular diseases, ECG Monitoring systems are used to detect abnormal heart functioning in patients.
Price: $4515 | Pre Book Price: $4515 | View Details >>

Skin is the outer covering of the human or animal’s body. It is the largest organ of the body and performs various functions such as protecting us from many harmful elements including microbes, enabling the sensations of heat, cold and touch and regulating our body temperatures. The goal of this report is to provide an overview of the global skincare devices markets with the current trends. Skincare devices are becoming popular due to the rising incidences of skin-related disorders. Additionally, they are widely used in aesthetics, which is a branch of philosophy dealing with beauty.
Price: $4515 | Pre Book Price: $4515 | View Details >>
NEED MORE INFORMATION?
Call
+1 617 674 413
PURCHASE OPTIONS

Single User
By obtaining a Single User License, you and your organization concur that only an individual uses this report either electronically or online. The right to use or stockpiling of the report should be confined only to one authorized computer. User will have authorization to print one duplicate of the report for individual use, yet may not be replicated for circulation. Additional copies for this report may also be order at discounted price for use by addition readers/users.
$4515

Multi User 
Multi-User license permits you to access the report from eight authorized computers. It does not permit you to display it on your company website and permits you to only print 5 copies of the report that shall not be reproduced for circulation.
$7515

Corporate  
With corporate use license, the complete or part of the content of the report can be shared or made available to other persons, other divisions and subsidiaries of same company. However, reproduction or redistribution of the report in is prohibited without the prior permission of Allied Market Research. The publisher will, in turn, regard the privacy of the purchaser and will keep it confidential. Upon buying single or multi-user license, buyer must provide the names and email ids of the authorized users of this report.
$10515


WHY ALLIED MARKET RESEARCH?
INFALLIBLE METHODOLOGY
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader






Top